title: Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation.
authors.affiliation: Gastroenterology Department, King's College Hospital, London, UK.
authors.forename: Polychronis
authors.initials: P
authors.lastname: Pavlidis
authors.affiliation: Institute of Liver Studies, King's College Hospital, London, UK.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Potts
authors.affiliation: Institute of Liver Studies, King's College Hospital, London, UK.
authors.forename: Ashley
authors.initials: A
authors.lastname: Barnabas
authors.affiliation: Institute of Liver Studies, King's College Hospital, London, UK.
authors.forename: Nigel
authors.initials: N
authors.lastname: Heaton
authors.affiliation: Gastroenterology Department, King's College Hospital, London, UK.
authors.forename: Ingvar
authors.initials: I
authors.lastname: Bjarnason
authors.affiliation: Institute of Liver Studies, King's College Hospital, London, UK.
authors.forename: Michael
authors.initials: M
authors.lastname: Heneghan
authors.affiliation: Gastroenterology Department, King's College Hospital, London, UK.
authors.forename: Bu'Hussain
authors.initials: B
authors.lastname: Hayee
mesh_terms: D000328:Adult; D001685:Biological Factors / Q000627:therapeutic use*; D015209:Cholangitis, Sclerosing / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D001685:Biological Factors; D014409:Tumor Necrosis Factor-alpha